There were 2,408 press releases posted in the last 24 hours and 440,364 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ゼナス・バイオファーマ (Zenas BioPharma)、IgG4関連疾患 (IgG4-RD) 治療薬オベキセリマブ (Obexelimab) の第2相臨床試験のランセット・リウマトロジー誌 (The Lancet Rheumatology) 掲載を発表

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image